UK's Croda trims upper end of annual profit forecast
Adds shares in paragraph 1 & 3, details on results throughout
July 30 (Reuters) -British chemicals group Croda International CRDA.L trimmed its annual profit expectations on Tuesday, hit by destocking and weak demand in its life sciences unit, sending shares down nearly 6%.
The company's life sciences unit houses segments such as crop protection and consumer health, which makes ingredients for over-the-counter medicines.
Shares in the FTSE 100 firm hit their lowest level since March 2020.
Barclays analysts earlier this month warned of problems for Croda, as extreme weather conditions disturb demand for crop-related chemicals.
However, Croda, which also supplies chemicals to makeup giant Estee Lauder EL.N, said its largest business, Consumer Care was benefiting from improved demand.
The company forecast adjusted profit before tax 260 million pounds ($334.1 million) and 280 million pounds for 2024, in line with market expectations, trimming the top end of its forecast down from 300 million pounds.
The firm had previously warned on its annual profits in February due to weakness in the crop business.
($1 = 0.7783 pounds)
Reporting by Prerna Bedi in Bengaluru; Editing by Varun H K
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
